Market Cap 2.43M
Revenue (ttm) 0.00
Net Income (ttm) -7.98M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 177,900
Avg Vol 89,236
Day's Range N/A - N/A
Shares Out 1.43M
Stochastic %K 81%
Beta 1.31
Analysts Strong Sell
Price Target $23.33

Company Profile

Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. The company's lead product is AD04, a serotonin-3 antagonist, which is in Phase 3 clinical trials for the treatment of alcohol use disorder. It is also involved in the development of drug candidates for non-opioid pain reduction and other diseases and disorders. Adial Pharmaceuticals, Inc. was founded in 2010 and i...

Industry: Biotechnology
Sector: Healthcare
Phone: 804 487 8196
Address:
4870 Sadler Road, Suite 300, Glen Allen, United States
kshonstocks
kshonstocks Mar. 20 at 5:29 PM
$ADIL on the off the bottom scan
0 · Reply
Shorty1010
Shorty1010 Mar. 20 at 4:09 PM
$ADIL a long position at $2.02 has been initiated. Now watching volume
0 · Reply
OatesTheGoat
OatesTheGoat Mar. 20 at 3:28 PM
$ADIL Breaking and holding over previous resistance
0 · Reply
tommy_john
tommy_john Mar. 20 at 12:51 AM
1 · Reply
uptrend2025
uptrend2025 Mar. 18 at 7:49 PM
$ADIL Major drug company doing due diligence on this one.
2 · Reply
AIBioScanner
AIBioScanner Mar. 18 at 4:42 PM
$ADIL AI-Based Findings on ADIL After running ADIL through my AI-driven quantitative framework, the stock remains in a clear downtrend with early signs of stabilization. ADIL is trading around $1.89, well below both the 20-day (~$2.18) and 50-day (~$3.82) moving averages — indicating continued weakness. Key signals: • Weak momentum (RSI low range) • MACD still negative • Range between $1.54 support and $7.00 resistance As shown in the chart, price is attempting to stabilize near recent lows after a prolonged decline. 1-Month Outlook: Base scenario: consolidation between $1.50–$2.50 Breakout above $2.50 could push toward $3.00+ Breakdown below $1.50 may extend downside Structure remains weak and requires confirmation before any reversal. Not financial advice.
0 · Reply
TheProbieAnalyst
TheProbieAnalyst Mar. 18 at 10:49 AM
1 · Reply
Chief_EZ
Chief_EZ Mar. 16 at 4:04 PM
$ADIL we should see a PR pump here before they raise more capital. $5 PT
0 · Reply
StayPresent
StayPresent Mar. 13 at 11:53 PM
$ADIL 7 pennies. That’s the value. 7 phuckin pennies of worthless shit.
0 · Reply
StayPresent
StayPresent Mar. 13 at 11:52 PM
$ADIL pos stock. Only hope is a p&d
0 · Reply
Latest News on ADIL
Adial Pharmaceuticals Completes Successful EOP2 FDA Meeting

Aug 6, 2025, 8:00 AM EDT - 8 months ago

Adial Pharmaceuticals Completes Successful EOP2 FDA Meeting


kshonstocks
kshonstocks Mar. 20 at 5:29 PM
$ADIL on the off the bottom scan
0 · Reply
Shorty1010
Shorty1010 Mar. 20 at 4:09 PM
$ADIL a long position at $2.02 has been initiated. Now watching volume
0 · Reply
OatesTheGoat
OatesTheGoat Mar. 20 at 3:28 PM
$ADIL Breaking and holding over previous resistance
0 · Reply
tommy_john
tommy_john Mar. 20 at 12:51 AM
1 · Reply
uptrend2025
uptrend2025 Mar. 18 at 7:49 PM
$ADIL Major drug company doing due diligence on this one.
2 · Reply
AIBioScanner
AIBioScanner Mar. 18 at 4:42 PM
$ADIL AI-Based Findings on ADIL After running ADIL through my AI-driven quantitative framework, the stock remains in a clear downtrend with early signs of stabilization. ADIL is trading around $1.89, well below both the 20-day (~$2.18) and 50-day (~$3.82) moving averages — indicating continued weakness. Key signals: • Weak momentum (RSI low range) • MACD still negative • Range between $1.54 support and $7.00 resistance As shown in the chart, price is attempting to stabilize near recent lows after a prolonged decline. 1-Month Outlook: Base scenario: consolidation between $1.50–$2.50 Breakout above $2.50 could push toward $3.00+ Breakdown below $1.50 may extend downside Structure remains weak and requires confirmation before any reversal. Not financial advice.
0 · Reply
TheProbieAnalyst
TheProbieAnalyst Mar. 18 at 10:49 AM
1 · Reply
Chief_EZ
Chief_EZ Mar. 16 at 4:04 PM
$ADIL we should see a PR pump here before they raise more capital. $5 PT
0 · Reply
StayPresent
StayPresent Mar. 13 at 11:53 PM
$ADIL 7 pennies. That’s the value. 7 phuckin pennies of worthless shit.
0 · Reply
StayPresent
StayPresent Mar. 13 at 11:52 PM
$ADIL pos stock. Only hope is a p&d
0 · Reply
DarkSonar
DarkSonar Mar. 13 at 5:41 PM
$ADIL Man!!! When would this little stock give us another massive parabolic run, this used to be so kind back in the day. I hope it gives a nice post R/S run, no position. Monitoring. 🔬
0 · Reply
TradeScouts
TradeScouts Mar. 13 at 6:00 AM
$ADIL The company signed a major collaboration framework with Molteni Farmaceutici for the European commercialization of AD04 (their lead drug for Alcohol Use Disorder). The deal could be worth nearly $60 million in milestones and royalties. $SOS On February 17, 2026, SOS announced the launch of SosBOT 1.0, an AI-driven trading bot.
1 · Reply
uptrend2025
uptrend2025 Mar. 11 at 7:35 PM
$ADIL $SXTP Buy low, sell high.
1 · Reply
Nycbroker1
Nycbroker1 Mar. 11 at 5:29 PM
$ADIL $SXTP This guy only promotes pump and dump garbage FYI
1 · Reply
uptrend2025
uptrend2025 Mar. 11 at 5:22 PM
$SXTP Told ya. $ADIL also has very compressed market cap, low float and pending signature of $60M royalty agreement. High price target.
1 · Reply
uptrend2025
uptrend2025 Mar. 11 at 4:38 PM
$ADIL Another one with Massive potential here.
0 · Reply
ResearchHills
ResearchHills Mar. 11 at 4:06 PM
$ADIL Litchfield Hills Research has released an update on Adial Pharma's positive news. The report, titled Significant new events increase our confidence of 2027-2028 commercialization is available on our website under the tab, Current Research.
0 · Reply
USAF71ITALY
USAF71ITALY Mar. 11 at 1:49 PM
@Zackpedia how about $ADIL
0 · Reply
TheFinalBet
TheFinalBet Mar. 11 at 10:33 AM
0 · Reply
TheFinalBet
TheFinalBet Mar. 11 at 10:31 AM
$ADIL looking good
0 · Reply
MiraAlc
MiraAlc Mar. 10 at 3:01 PM
$ADIL Biotech microcap, asymmetry high into catalyst
0 · Reply
StayPresent
StayPresent Mar. 10 at 12:10 PM
$ADIL just look at this garbage drop. No relief in sight. Sad.
0 · Reply